Global framework for biosimilars "is now crucial"

Article Date: 25/04/2012 06:00
Global framework for biosimilars "is now crucial"

Vacancy Search

Quick job search

Advanced Search

Latest News

Lilly sells failed cancer drug enzastaurin to Denovo

Lilly sells failed cancer drug enzastaurin to Denovo

Pfizer buys into potential of GDNF for Parkinson's

Pfizer buys into potential of GDNF for Parkinson's

US orphan status for NovaBiotics' CF drug

US orphan status for NovaBiotics' CF drug

UK pharma trade surplus set to widen, says HSBC

UK pharma trade surplus set to widen, says HSBC

FDA approves AstraZeneca's constipation drug Movantik

FDA approves AstraZeneca's constipation drug Movantik

NW Bio cancer therapy first in UK early access scheme

NW Bio cancer therapy first in UK early access scheme

UK's Plethora premature ejaculation pact with Recordati

UK's Plethora premature ejaculation pact with Recordati

Shire gets Vyvanse priority review for binge eating disorder

Shire gets Vyvanse priority review for binge eating disorder

AZ could bank $500 million in Lilly Alzheimer's alliance

AZ could bank $500 million in Lilly Alzheimer's alliance

Alere’s founder raises $8.6bn to get his baby back

Well, it makes a change from mergers. If its former chief executive gets his way, the diagnostics company Alere will be taken private at $46 a share, a 25% premium to Friday’s close. The...
more news